Literature DB >> 28940423

The Patient Protection and Affordable Care Act dependent coverage expansion: Disparities in impact among young adult oncology patients.

Elysia M Alvarez1, Theresa H Keegan2, Emily E Johnston1, Robert Haile3, Lee Sanders4, Paul H Wise5, Olga Saynina5, Lisa J Chamberlain4.   

Abstract

BACKGROUND: Private health insurance is associated with improved outcomes in patients with cancer. However, to the authors' knowledge, little is known regarding the impact of the Patient Protection and Affordable Care Act Dependent Coverage Expansion (ACA-DCE), which extended private insurance to young adults (to age 26 years) beginning in 2010, on the insurance status of young adults with cancer.
METHODS: The current study was a retrospective, population-based analysis of hospitalized young adult oncology patients (aged 22-30 years) in California during 2006 through 2014 (11,062 patients). Multivariable regression analyses examined factors associated with having private insurance. Results were presented as adjusted odds ratios and 95% confidence intervals. A difference-in-difference analysis examined the influence of the ACA-DCE on insurance coverage by race/ethnicity and federal poverty level.
RESULTS: Multivariable regression demonstrated that patients of black and Hispanic race/ethnicity were less likely to have private insurance before and after the ACA-DCE, compared with white patients. Younger age (22-25 years) was associated with having private insurance after implementation of the ACA-DCE (odds ratio, 1.20; 95% confidence interval, 1.06-1.35). In the difference-in-difference analysis, private insurance increased among white patients aged 22 to 25 years who were living in medium-income (2006-2009: 64.6% vs 2011-2014: 69.1%; P = .003) and high-income (80.4% vs 82%; P = .043) zip codes and among Asians aged 22 to 25 years living in high-income zip codes (73.2 vs 85.7%; P = .022). Private insurance decreased for all Hispanic patients aged 22 to 25 years between the 2 time periods.
CONCLUSIONS: The ACA-DCE provision increased insurance coverage, but not among all patients. Private insurance increased for white and Asian patients in higher income neighborhoods, potentially widening social disparities in private insurance coverage among young adults with cancer. Cancer 2018;124:110-7.
© 2017 American Cancer Society. © 2017 American Cancer Society.

Entities:  

Keywords:  Patient Protection and Affordable Care Act; dependent coverage expansion; disparities; insurance; young adult

Mesh:

Year:  2017        PMID: 28940423     DOI: 10.1002/cncr.30978

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Treatment Complications and Survival Among Children and Young Adults With Acute Lymphoblastic Leukemia.

Authors:  Elysia M Alvarez; Marcio Malogolowkin; Jeffrey S Hoch; Qian Li; Ann Brunson; Brad H Pollock; Lori Muffly; Ted Wun; Theresa H M Keegan
Journal:  JCO Oncol Pract       Date:  2020-06-11

2.  Taboo Topics in Adolescent and Young Adult Oncology: Strategies for Managing Challenging but Important Conversations Central to Adolescent and Young Adult Cancer Survivorship.

Authors:  Giselle K Perez; John M Salsman; Kaitlyn Fladeboe; Anne C Kirchhoff; Elyse R Park; Abby R Rosenberg
Journal:  Am Soc Clin Oncol Educ Book       Date:  2020-03

Review 3.  Adolescent angst: enrollment on clinical trials.

Authors:  Theresa H M Keegan; Helen M Parsons
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

4.  Impact of Health Insurance on Stage at Cancer Diagnosis Among Adolescents and Young Adults.

Authors:  Theresa H M Keegan; Helen M Parsons; Yi Chen; Frances B Maguire; Cyllene R Morris; Arti Parikh-Patel; Kenneth W Kizer; Ted Wun
Journal:  J Natl Cancer Inst       Date:  2019-11-01       Impact factor: 13.506

Review 5.  Understanding, measuring, and addressing the financial impact of cancer on adolescents and young adults.

Authors:  John M Salsman; Kristin Bingen; Ronald D Barr; David R Freyer
Journal:  Pediatr Blood Cancer       Date:  2019-02-12       Impact factor: 3.167

6.  Use of Communication Technology to Improve Clinical Trial Participation in Adolescents and Young Adults With Cancer: Consensus Statement From the Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network.

Authors:  Viswatej Avutu; Varun Monga; Nupur Mittal; Aniket Saha; Jeffrey R Andolina; Danielle E Bell; Douglas B Fair; Jamie E Flerlage; Jamie N Frediani; Jessica L Heath; Justine M Kahn; Jennifer L Reichek; Leanne Super; Michael A Terao; David R Freyer; Michael E Roth
Journal:  JCO Oncol Pract       Date:  2021-12-14

7.  Voicing their choices: Advance care planning with adolescents and young adults with cancer and other serious conditions.

Authors:  Lori Wiener; Sima Bedoya; Haven Battles; Leonard Sender; Keri Zabokrtsky; Kristine A Donovan; Lora M A Thompson; Barbara B Lubrano di Ciccone; Margarita Bobonis Babilonia; Karen Fasciano; Paige Malinowski; Maureen Lyon; Jessica Thompkins; Corey Heath; Denise Velazquez; Karen Long-Traynor; Abigail Fry; Maryland Pao
Journal:  Palliat Support Care       Date:  2022-08

8.  Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014.

Authors:  Quinn T Ostrom; David J Cote; Mustafa Ascha; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  JAMA Oncol       Date:  2018-09-01       Impact factor: 31.777

9.  Age-Related Differences in Financial Toxicity and Unmet Resource Needs Among Adolescent and Young Adult Cancer Patients.

Authors:  Heydon K Kaddas; Samantha T Pannier; Karely Mann; Austin R Waters; Sara Salmon; Tomoko Tsukamoto; Echo L Warner; Brynn Fowler; Mark A Lewis; Douglas B Fair; Anne C Kirchhoff
Journal:  J Adolesc Young Adult Oncol       Date:  2019-09-16       Impact factor: 2.223

10.  Disparities in insurance coverage among hospitalized adult congenital heart disease patients before and after the Affordable Care Act.

Authors:  Katherine B Salciccioli; Jason L Salemi; Christopher R Broda; Keila N Lopez
Journal:  Birth Defects Res       Date:  2021-02-15       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.